Developer docs
API playgroundTry for free, no card

Search company profiles

Reify Health

Full company profile

uuid000347w

Namestring
Reify Health
Legal namestring
Reify Health, Inc.
Websiteurl
reifyhealth.com
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial software, clinical research platform, decentralized clinical trials, patient enrollment solutions, trial site management
Industry1 code
1Cross-Organization Care Coordination & Referral Interoperability (ADT, eReferrals, transitions of care)
CodeHLACABAOPrimaryYes
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Technology Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Platform SaaS Subscription
TypeSubscription Recurring
Description

Reify Health operates StudyTeam as a software platform connecting clinical trial stakeholders. The company generates revenue through platform subscriptions and software services to pharmaceutical sponsors and research sites. The model enables collaboration between sites and sponsors, with value derived from improved trial enrollment efficiency and reduced operational bottlenecks.

reifyhealth.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1StudyTeam
Description

Connected technology platform for clinical trial workflows, helping sites and sponsors work together on a common platform for pre-screening and enrolling studies

reifyhealth.com
Core offering1 text field

Reify Health is a cloud-based software company that develops and operates the StudyTeam platform (via its OneStudyTeam business unit), a unified workflow system that connects research sites, pharmaceutical sponsors, patients, and other clinical trial stakeholders for real-time collaboration on trial enrollment and operations. In parallel, its Care Access business unit builds and operates clinical research sites in underserved communities, expanding trial capacity and improving diversity and representation in clinical research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Expanded to more than 10,000 research sites globally
+2 more records
Product overview1 text field

Reify Health operates as a unified platform company with two main business units: OneStudyTeam and Care Access. OneStudyTeam encompasses the StudyTeam technology platform, which connects research sites, sponsors, patients, and other stakeholders on a common platform to streamline clinical trial enrollment and workflow management. Care Access focuses on expanding clinical trial access by building research sites and partnerships in underserved communities. Together, these products address the clinical trial bottleneck by increasing capacity and connecting the clinical trial ecosystem to work together more seamlessly.

Product and service2 records
1StudyTeam (operated by OneStudyTeam)
CategoryClinical Trial Technology Platform
Description

Cloud-based unified workflow platform that connects research sites, pharmaceutical sponsors, patients, technology vendors, and regulatory agencies on a common platform for clinical trial pre-screening and enrollment, providing sponsors with real-time enrollment visibility and sites with streamlined study workflows. Sold to pharmaceutical sponsors and research sites as an enterprise SaaS subscription.

2Care Access
CategoryClinical Trial Site Network Services
Description

Site-network service that systematically builds and operates clinical research sites in underserved communities, partnering with new-to-research physicians to expand clinical trial access for patients, communities, and healthcare providers. Operates as a wholly-owned business unit within Reify Health alongside OneStudyTeam.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-22
Description

Reify Health is a founding member of the BRIDGE Initiative, which focuses on promoting diversity and improving representation in clinical trials. This initiative aligns with the company's mission to expand access to clinical trials for underserved communities.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers6 records
TypeBroad incumbent
Description

Medidata (a Dassault Systèmes company) is a long-established clinical trial technology platform offering EDC, CTMS, RTSM, and patient engagement solutions. It is directly comparable to Reify's OneStudyTeam as a sponsor-facing platform connecting trial stakeholders, though Medidata operates as a broader incumbent serving the full clinical trial technology stack.

TypeBroad incumbent
Description

Veeva Systems provides cloud-based software for life sciences including CTMS, eTMF, and clinical data management. Its Vault Clinical platform competes with Reify's OneStudyTeam for sponsor-side trial operations budgets, and Veeva's deep enterprise relationships with large pharma make it the most entrenched incumbent in clinical trial technology.

TypeBroad incumbent
Description

Oracle Clinical One is a unified clinical trial platform providing EDC, RTSM, patient engagement, and trial design capabilities. Acquired through Oracle's purchase of Phase Forward, it competes directly with Reify for sponsor-side clinical trial technology spend, with Oracle's broader enterprise infrastructure providing significant distribution advantages.

TypeDirect peer
Description

Castor is a clinical trial data capture platform serving sponsors and CROs with EDC, ePRO, and eConsent capabilities. It is a direct peer to Reify's OneStudyTeam in the clinical trial workflow software category, with overlapping customer segments and similar focus on decentralized trial enablement.

TypeEmerging player
Description

Science 37 is a decentralized clinical trial platform operating a hybrid site network and patient recruitment technology. It is comparable to Reify's combined OneStudyTeam and Care Access model as a vertically integrated decentralized trial operator, though with more emphasis on fully remote trial conduct.

6Headlands Research (formerly TrialSpark)
Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reify Health

Clinical Trial Technology Softwarereifyhealth.com

Reify Health firmographics

Firmographics
Name
Reify Health
Legal name
Reify Health, Inc.
Website
https://reifyhealth.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Reify Health industry classification

Industry
Product category
Clinical Trial Technology Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Cross-Organization Care Coordination & Referral Interoperability (ADT, eReferrals, transitions of care) (HLACABAO)

Keywords

  • Clinical trial software
  • Clinical research platform
  • Decentralized clinical trials
  • Patient enrollment solutions
  • Trial site management

Where Reify Health is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Reify Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Platform SaaS Subscription: Reify Health operates StudyTeam as a software platform connecting clinical trial stakeholders. The company generates revenue through platform subscriptions and software services to pharmaceutical sponsors and research sites. The model enables collaboration between sites and sponsors, with value derived from improved trial enrollment efficiency and reduced operational bottlenecks.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Reify Health product offering

Product offering

Core offering

Reify Health is a cloud-based software company that develops and operates the StudyTeam platform (via its OneStudyTeam business unit), a unified workflow system that connects research sites, pharmaceutical sponsors, patients, and other clinical trial stakeholders for real-time collaboration on trial enrollment and operations. In parallel, its Care Access business unit builds and operates clinical research sites in underserved communities, expanding trial capacity and improving diversity and representation in clinical research.

Product overview

Reify Health operates as a unified platform company with two main business units: OneStudyTeam and Care Access. OneStudyTeam encompasses the StudyTeam technology platform, which connects research sites, sponsors, patients, and other stakeholders on a common platform to streamline clinical trial enrollment and workflow management. Care Access focuses on expanding clinical trial access by building research sites and partnerships in underserved communities. Together, these products address the clinical trial bottleneck by increasing capacity and connecting the clinical trial ecosystem to work together more seamlessly.

Differentiator

Problem solved

Functional benefit

Brands

  • StudyTeam: Connected technology platform for clinical trial workflows, helping sites and sponsors work together on a common platform for pre-screening and enrolling studies

Products and services

  • StudyTeam (operated by OneStudyTeam) Cloud-based unified workflow platform that connects research sites, pharmaceutical sponsors, patients, technology vendors, and regulatory agencies on a common platform for clinical trial pre-screening and enrollment, providing sponsors with real-time enrollment visibility and sites with streamlined study workflows. Sold to pharmaceutical sponsors and research sites as an enterprise SaaS subscription.
  • Care Access Site-network service that systematically builds and operates clinical research sites in underserved communities, partnering with new-to-research physicians to expand clinical trial access for patients, communities, and healthcare providers. Operates as a wholly-owned business unit within Reify Health alongside OneStudyTeam.

Quantifiable outcome

  • Expanded to more than 10,000 research sites globally
  • +2 more outcomes

Companies that use Reify Health

Customer profile

Segments3 records

Ideal customer profiles2 records

Reify Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Reify Health partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BRIDGE InitiativecoreStrategic or Co-development Partner · 22 September 2022Reify Health is a founding member of the BRIDGE Initiative, which focuses on promoting diversity and improving representation in clinical trials. This initiative aligns with the company's mission to expand access to clinical trials for underserved communities.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Reify Health competitors and assessment

Company assessment

Broad incumbents

  • Medidata Solutions: Medidata (a Dassault Systèmes company) is a long-established clinical trial technology platform offering EDC, CTMS, RTSM, and patient engagement solutions. It is directly comparable to Reify's OneStudyTeam as a sponsor-facing platform connecting trial stakeholders, though Medidata operates as a broader incumbent serving the full clinical trial technology stack.
  • Veeva Systems: Veeva Systems provides cloud-based software for life sciences including CTMS, eTMF, and clinical data management. Its Vault Clinical platform competes with Reify's OneStudyTeam for sponsor-side trial operations budgets, and Veeva's deep enterprise relationships with large pharma make it the most entrenched incumbent in clinical trial technology.
  • Oracle Clinical One: Oracle Clinical One is a unified clinical trial platform providing EDC, RTSM, patient engagement, and trial design capabilities. Acquired through Oracle's purchase of Phase Forward, it competes directly with Reify for sponsor-side clinical trial technology spend, with Oracle's broader enterprise infrastructure providing significant distribution advantages.

Direct peers

  • Castor EDC: Castor is a clinical trial data capture platform serving sponsors and CROs with EDC, ePRO, and eConsent capabilities. It is a direct peer to Reify's OneStudyTeam in the clinical trial workflow software category, with overlapping customer segments and similar focus on decentralized trial enablement.

Emerging players

  • Science 37: Science 37 is a decentralized clinical trial platform operating a hybrid site network and patient recruitment technology. It is comparable to Reify's combined OneStudyTeam and Care Access model as a vertically integrated decentralized trial operator, though with more emphasis on fully remote trial conduct.

Peers

  • Headlands Research (formerly TrialSpark):

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Reify Health social profiles

Digital presence

Reify Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reify Health leadership team

Management profile

Number of profiles

Profiles8 records

Reify Health subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Reify Health funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reify Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reify Health

What does Reify Health do?

Reify Health is a cloud-based software company that develops and operates the StudyTeam platform (via its OneStudyTeam business unit), a unified workflow system that connects research sites, pharmaceutical sponsors, patients, and other clinical trial stakeholders for real-time collaboration on trial enrollment and operations. In parallel, its Care Access business unit builds and operates clinical research sites in underserved communities, expanding trial capacity and improving diversity and representation in clinical research.

Is Reify Health a public or private company?

Reify Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Reify Health founded?

Reify Health was founded in 2015. It employs 501 to 1,000 people.

Where is Reify Health based?

Reify Health is headquartered in Boston, United States, in the North America region.

How does Reify Health make money?

One revenue line is on record: platform SaaS Subscription.

Who are Reify Health's main competitors?

Broad incumbents on record are Medidata Solutions, Veeva Systems and Oracle Clinical One. Castor EDC is listed as a direct peer. Science 37 is listed as an emerging player. Headlands Research (formerly TrialSpark) is listed as a peer.

Does Reify Health have an API?

No public API is recorded for Reify Health.

What industry is Reify Health in?

Reify Health's product category is Clinical Trial Technology Software. Its primary akta.pro industry code is HLACABAO, Cross-Organization Care Coordination & Referral Interoperability (ADT, eReferrals, transitions of care). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Applied Clinical TrialsWorkflow Optimization Moves to Clinical TrialsReify Health, a clinical trial workflow technology company, is featured in an interview discussing how its StudyTeam platform addresses recruitment and enrollment inefficiencies in clinical trials. The company states that $4B is spent annually on clinical trial technologies but little focuses on site-level recruitment, with 90% of trials experiencing delays averaging over a month. Reify claims its platform reduces enrollment timelines by 6 weeks on average and increases patient recruitment by 16% per site per month, serving half of the top-20 global biopharmaceutical companies.RedditReify Health Raises $220 Million to Eliminate Waiting in Clinical Trials : rReify Health raised $220 million to support efforts to eliminate waiting times in clinical trials. The article also mentions Rocket Companies' acquisition of Redfin stock, but does not specify its strategic implications.B2B SaaS BlogReify Health Revenue 2025: $189M Est. ARR, $4.8B ValuationReify Health is estimated to have reached $189 million in Annual Recurring Revenue (ARR) for 2025, maintaining the $4.8 billion valuation it achieved during its 2022 Series D funding round. The company provides clinical trial optimization software and infrastructure through its entities OneStudyTeam and Care Access to accelerate drug development for biopharma partners.BatteryJobs at Reify HealthReify Health provides trial optimization software and clinical trial infrastructure through its entities OneStudyTeam and Care Access. The company partners with biopharma companies, research clinics, and healthcare organizations to accelerate new medicines to patients. The page lists job openings but none are currently available.ThlThe Future of Pharmaceuticals: How Technology, Big Data, and AI May Help Speed Drug DevelopmentTiger Hill hosted a panel discussion in Fall 2023 featuring executives from TriNetX, Syneos Health, and Reify Health to analyze how artificial intelligence and big data are transforming pharmaceutical clinical trials. The discussion highlighted that these technologies can significantly reduce the typical 10-15 year timeline and $2.6 billion cost of bringing new drugs to market by optimizing patient recruitment, protocol adherence, and decision-making processes.ZoominfoReify Health - Overview, News & Similar companiesReify Health announced a $220 million Series D funding round co-led by Altimeter Capital and Coatue, bringing its valuation to over $4.8 billion. The company is utilizing the capital to accelerate efforts to improve diversity and representation in clinical trial participation through its platforms, including the rollout of StudyTeam Diversity Reporting.SwotanalysisReify Health SWOT Analysis & Strategic Plan 2025-Q4Alignment.io published a comprehensive strategic analysis of Reify Health for Q4 2025, evaluating its SWOT profile, OKR execution, and AI strategy. The report highlights Reify's strong market position driven by its extensive clinical site network and $500M+ funding, while identifying significant competitive threats from Veeva Systems and IQVIA. Key strategic priorities include deepening EMR integration, scaling the Care Access service model, and developing predictive AI capabilities to secure a technological moat.Built In BostonAs More Clinical Trials Go Remote, New Unicorn Reify Health Raises $220MReify Health, a Boston-based startup focused on digitizing clinical trials, has raised $220 million in Series C funding led by Coatue Management, valuing the company at $2.2 billion. The funding will be used to scale its StudyTeam and Care Access platforms, which aim to decentralize trial participation and reduce enrollment times for biopharmaceutical partners like AstraZeneca and Eli Lilly. This investment supports Reify's expansion of its mobile site vehicles and headcount to meet surging demand for remote clinical trial infrastructure.CB InsightsProducts, Competitors, Financials, Employees, Headquarters LocationsA company profile describes Reify Health, formerly ZeroSum Health, a Boston-based firm founded in 2012 that provides cloud-based software and infrastructure for clinical trial enrollment and research. It was named an Outperformer among 15 companies in a trial recruitment optimization tools market ranking, and holds one granted patent. The page also cites a report projecting the global virtual clinical trials market at $17.43 billion in 2028.American City Business JournalsEntrepreneur: Ralph Passarella and Michael LinRalph Passarella and Michael Lin co-founded Boston-based Reify Health to remove operational barriers in clinical trials. The company has launched initiatives to expand access for patients and providers by integrating new research sites and digitizing workflows.